Sentio MMG is a surgical access tool used to locate and map motor nerve roots and their peripheral extensions originating from spinal levels C3-T1 and L2-S2. Sentio is currently cleared for use in the United States by the U.S. Food and Drug Administration to assist in locating and mapping motor nerves.
“This co-marketing strategy strengthens our position at the forefront of minimally invasive spine surgery technologies,” said Trent J. Northcutt, president and CEO of Aurora Spine. “We are excited about our relationship with Sentio MMG in conjunction with our VOX MIS lateral interbody system featuring TiNANO. The Sentio system was specifically designed to facilitate safe MMG monitoring during any MIS spine surgery. Aurora and Sentio share a vision to improve spine patient outcomes, drive continued surgeon interest and bolster relevance as key innovators in spine.”
More articles on devices:
What’s going on at Medtronic Spine? Innovations coming down the pipe
Medtronic’s new ACDF device designed to streamline procedures
Materialise buys OrthoView — 5 quick facts
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
